Immunity challenge

Rybka, Ted
June 2005
Echo Magazine;6/2/2005, Vol. 16 Issue 19, p53
Interviews Doctor Jon Kaiser about AIDS. Effectiveness of his HIV/AIDS treatment plan; Changes in the development and treatment of HIV and AIDS; Views on the efficiency of the combination of vitamin supplements and antiviral therapy in treating HIV and AIDS.


Related Articles

  • Attitudes to HIV testing in general practice. Kellock, D. J.; Rogstad, K. E. // International Journal of STD & AIDS;May1998, Vol. 9 Issue 5, p263 

    Newer therapies for the treatment of HIV infection and the effectiveness of zidovudine in reducing vertical transmission mean that it is becoming increasingly important to diagnose HIV infection earlier. General practitioners (GPs) attending a local study day on sexually transmitted diseases...

  • Enfuvirtide Added to an Optimized Antiretroviral Regimen Provided Significant Benefits in Patients with Multidrug-Resistant HIV Infection. Lorber, Bennett // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p877 

    The article presents information on papers related to infectious diseases in the U.S. The paper "Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America," by J.P. Lalezari, K. Henry, M. O'Hearn et al. studied that enfuvirtide added to an optimized...

  • Denying science.  // Nature Medicine;Apr2006, Vol. 12 Issue 4, p369 

    The article comments on the movement of AIDS denialists in spreading conspiracy theories and misinformation to a susceptible public wary of antiretroviral drugs. Scientists have a very important role to play in explaining the science behind AIDS and showing that antiretroviral drugs can...

  • Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection. Papasavvas, Emmanouil; Kostman, Jary R.; Mounzer, Karam; Grant, Robert M.; Gross, Robert; Gallo, Cele; Azzoni, Livio; Foulkes, Andrea; Thiel, Brian; Pistilli, Maxwell; Mackiewicz, Agnieszka; Shull, Jane; Montaner, Luis J. // PLoS Medicine;Dec2004, Vol. 1 Issue 3, p218 

    Background Approaches to limiting exposure to antiretroviral therapy (ART) drugs are an active area of HIV therapy research. Here we present longitudinal follow-up of a randomized, open-label, single-center study of the immune, viral, and safety outcomes of structured therapy interruptions (TIs)...

  • Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study. Machado, Carmen; Jos‚ R¡os-Villegas, Mar¡a; G lvez-Acebal, Juan; Dom¡nguez-Castellano, Angel; Fern ndez-Cuenca, Felipe; Palomo, Virginia; Angel Muniain, Miguel; Rodr¡guez-Ba¤o, Jes£s // BMC Research Notes;2012, Vol. 5 Issue 1, p578 

    Background: To describe the long term outcome of patients who interrupted highly active antiretroviral therapy (HAART) once, identify the variables associated with earlier need to re-start HAART, and the response when therapy was resumed. A retrospective observational cohort of 66 adult patients...

  • Ministers dump bird flu burden at door of GPs.  // Pulse;10/22/2005, Vol. 65 Issue 41, p1 

    Reports on the call of the British government for general practitioners to take crucial decisions on how to isolate patients and distribute anti-viral drugs when bird flu strike. Provision of practice contingency plans to combat the flue; Distribution of the drugs for home visits; Factors to...

  • Corroborative Study Confirmed That Adding Enfuvirtide to an Optimized Antiretroviral Regimen Benefited Patients with Multidrug-Resistant HIV Infection. Lorber, Bennett // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p878 

    The article presents information on papers related to infectious diseases in Europe and Australia. The paper "Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia," by A. Lazzarin, B. Clotet, D. Cooper, et al. confirmed that adding enfuvirtide to an...

  • Physician Beliefs about Antiretroviral Adherence Communication. Roberts, Kathleen Johnston // AIDS Patient Care & STDs;Sep2000, Vol. 14 Issue 9, p477 

    Adherence to antiretroviral regimens is thought to be imperative for HIV-positive patients. However, little is known about health care professionals' willingness to discuss adherence with patients, nor what barriers, if any, may impede their adherence communication. The aims of the study were to...

  • The Potential Role of Buprenorphine in the Treatment of Opioid Dependence in HIV-Infected Individuals and in HIV Infection Prevention. Altice, Frederick L.; Sullivan, Lynn E.; Smith-Rohrberg, Duncan; Basu, Sanjay; Stancliff, Sharon; Eldred, Lois // Clinical Infectious Diseases;12/15/2006 Supplement, Vol. 43, pS178 

    Untreated opioid dependence is a major obstacle to the successful treatment and prevention of human immunodeficiency virus (HIV) infection. In this review, we examine the interwoven epidemics of HIV infection and opioid dependence and the emerging role of buprenorphine in improving HIV treatment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics